Scientific Program

*It is based on the local time of Seoul, Korea (UTC/ GMT +9:00) Updated as of July 3

November 21 (Thu)

Educational Session 1 - Targeting RAS in cancer

Date & Time 11/21(Thu) 08:30 – 10:10 Place Crystal Ballroom (2F)
  • ·
  • Cell type-specific Kras mutation in gastric and pancreatic carcinogenesis

    Su-Hyung Lee (Vanderbilt University, USA)

  • ·
  • The way of Ras inhibitors, paved with failures

    Dae Ho Lee (University of Ulsan College of Medicine)

  • ·
  • To be announced

    Andrew J. Aguirre (Dana-Farber Cancer Institute, USA)

  • ·
  • To be announced

    Eileen O’Reilly (Memorial Sloan-Kettering Cancer Center, USA)

Keynote Lecture

Date & Time 11/21 (Thu) 10:30 – 11:10 Place Crystal Ballroom (2F)
  • ·
  • To be announced (AACR)

Plenary Session 1 - Patient derived models

Date & Time 11/21 (Thu) 12:30 – 14:10 Place Crystal Ballroom (2F)
  • ·
  • Cancer research models using patient-derived xenograft(PDX) and PDX-derived organoid(PDXO)

    Jong-il Kim (Seoul National University)

  • ·
  • Microscale tools to simulate cancer metastasis

    Seok Chung (Korea University)

  • ·
  • To be announced

    Berend Snijder (ETH Zurich, Switzerland)

  • ·
  • To be announced

    Edward Kai-Hua Chow (National University of Singapore, Singapore)

Plenary Session 2 - Tumor heterogeneity

Date & Time 11/21 (Thu) 14:30 – 16:10 Place Crystal Ballroom (2F)
  • ·
  • Modeling cancer timelines to unravel cancer transitions and predict prevention strategies

    Dongkwan Shin(National Cancer Center)

  • ·
  • Multifocal organoid capturing of colon cancer reveals pervasive intratumoral heterogenous drug responses

    Soon-Chan Kim(Seoul National University)

  • ·
  • To be announced (AACR)

  • ·
  • To be announced (AACR)

November 22 (Fri)

Educational Session 2 - Cancer neuroscience

Date & Time 11/22(Fri) 08:00 – 09:30 Place Crystal Ballroom (2F)
  • ·
  • Regulation of anti-tumoral immunity via brain-bone interactions

    Serk-in Park (Korea University)

  • ·
  • To be announced

    Varun Venkatramani (Heidelberg University, Germany)

  • ·
  • To be announced (AACR)

Plenary Session 3 - EBV related cancers

Date & Time 11/22 (Fri) 09:40 – 11:20 Place Crystal Ballroom (2F)
  • ·
  • EBV-positive gastric cancer: Future perspectives and therapeutic challenges

    Kyung-Mee Kim (Sungkyunkwan University)

  • ·
  • Epstein-Barr virus immunity and a novel cytotoxic CD4+ T cell approach for B cell malignancies

    Il-Kyu Choi (DGIST)

  • ·
  • To be announced

    Mu-Shen Zeng (Sun Yat-Sen University Cancer Center, China)

  • ·
  • To be announced

    Rajiv Khanna (QIMR Berghofer, Australia)

Waun Ki Hong Memorial Lecture

Date & Time 11/22 (Fri) 11:40 – 12:20 Place Crystal Ballroom (2F)
  • ·
  • To be announced

    Yeul Hong Kim(Yuhan Cooperation)

Plenary Session 4 - AI in cancer research and treatment

Date & Time 11/22 (Fri) 13:40 – 15:20 Place Crystal Ballroom (2F)
  • ·
  • Digital Pathology and AI for gastrointestinal and hepatobiliary cancers

    Sung Hak Lee (The Catholic University of Korea)

  • ·
  • Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer

    Changhwan Sung (University of Ulsan College of Medicine)

  • ·
  • To be announced (AACR)

  • ·
  • To be announced (AACR)

Plenary Session 5 - Advances in immuno-oncology

Date & Time 11/22 (Fri) 15:40 – 17:20 Place Crystal Ballroom (2F)
  • ·
  • Leveraging 4-1BB as a target for T cell activation and Treg depletion through a bispecific antibody

    Sang Hoon Lee (ABL bio)

  • ·
  • Deciphering natural killer cells' secretomes and their influence on immune activation

    Kyung-Soon Park (CHA University)

  • ·
  • To be announced

    Allison Betof Warner (Stanford University, USA)

  • ·
  • To be announced (AACR)